PULSE BIOSCIENCES, INC. — Director's Dealing 2023

Dec 9, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2023-12-06

Reporting Person: DUGGAN ROBERT W (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-06	Common Stock	M	9933	$5.95	Acquired	36601741	Direct
2023-12-06	Common Stock	P	82813	$9.06	Acquired	36684554	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-12-06	Stock Option (right to buy)	$5.95	M	9933	Disposed	2033-05-25	Common Stock (9933)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	351565	Indirect
Common Stock	492069	Indirect

Footnotes

F1: Volume-weighted average price.

F2: Shares are held by Blazon Corporation, of which the Reporting Person is the majority shareholder.

F3: Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.

F4: Pursuant to the Company's Amended and Restated Outside Director Compensation Policy, this option vests on a quarterly basis following the Company's 2023 Annual Stockholder Meeting.